Market Cap 603.73M
Revenue (ttm) 332.07M
Net Income (ttm) 18.25M
EPS (ttm) N/A
PE Ratio 35.45
Forward PE N/A
Profit Margin 5.50%
Debt to Equity Ratio 0.02
Volume 298,200
Avg Vol 428,644
Day's Range N/A - N/A
Shares Out 28.85M
Stochastic %K 34%
Beta 1.11
Analysts Strong Sell
Price Target $38.33

Latest News on CSTL

Castle Biosciences, Inc. (CSTL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 10:09 PM EST - 2 months ago

Castle Biosciences, Inc. (CSTL) Q4 2024 Earnings Call Transcript


Castle Biosciences Reports Third Quarter 2024 Results

Nov 4, 2024, 4:05 PM EST - 6 months ago

Castle Biosciences Reports Third Quarter 2024 Results


Castle Biosciences: Inflection Into Profitability

Aug 16, 2024, 6:41 AM EDT - 9 months ago

Castle Biosciences: Inflection Into Profitability


Castle Biosciences, Inc. (CSTL) Q2 2024 Earnings Call Transcript

Aug 5, 2024, 10:35 PM EDT - 9 months ago

Castle Biosciences, Inc. (CSTL) Q2 2024 Earnings Call Transcript


Castle Biosciences Reports Second Quarter 2024 Results

Aug 5, 2024, 4:05 PM EDT - 9 months ago

Castle Biosciences Reports Second Quarter 2024 Results


Castle Biosciences Honored with Top Workplaces Awards

Jul 11, 2024, 7:00 AM EDT - 10 months ago

Castle Biosciences Honored with Top Workplaces Awards


Top 5 Health Care Stocks That May Explode In July

Jul 8, 2024, 8:40 AM EDT - 10 months ago

Top 5 Health Care Stocks That May Explode In July

NRC OMI PCRX SAVA